Utilization of Oil Palm Empty Bunches Waste as Biochar-microbes for Improving Availability of Soil Nutrients

There are about 23% waste oil palm empty fruit bunches (OPEFB) of total waste generated from the production of crude palm oil in oil palm plantations. Pyrolysis technology can be used to convert waste into biochar and further can be utilized for the improvement of soil. Biochar-microbes of OPEFB are biochar from OPEFB biomass that enriched with soil microbes. Biochar-microbes is expected to be used for the improvement of the soil and plants. Therefore the purpose of this research was to study the ability of biochar-microbes OPEFB to increase availability of the nutrients in sandy soils. The process of making biochar done by using slow pyrolysis technology by heating 300oC and 400oC for 2 and 3 hours, and with sizes 40 and 80 mesh, as well as indigenous microbial Bulkhorderia nodosa G.52.Rif1 and Trichoderma sp.) added. The biochar production and research were conducted in the Department of Forestry Laboratory and in the Department of Agronomy Laboratory, Faculty of Agriculture, Palangka Raya University. In general, the study showed that biochar-microbes could maintain the soil pH value and tends to increase the soil pH, increasing the holding capacity of sandy soil to the elements of P and K as well as increasing the availability of nutrients N, P and K. Furthermore, this study showed that the biochar process by 400oC heating for 3 hours and 40 mesh with microbes or without microbes were the best effect on the improvement of the quality of holding capacity and the nutrients supply in sandy soils

Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death

Multiple Myeloma (MM) is a lymphatic neoplasm characterized by clonal proliferation of malignant plasma cell that eventually develops resistance to chemotherapy. Drug resistance, differentiation block and increased survival of the MM tumor cells result from high genomic instability. Chromosomal translocations, the most common genomic alterations in MM, lead to dysregulation of cyclin D, a regulatory protein that governs the activation of key cell cycle regulator – cyclin dependent kinase (CDK). Genomic instability was reported to be affected by over expression of another CDK regulator - cyclin E (CCNE). This occurs early in tumorigenesis in various lymphatic malignancies including CLL, NHL and HL. We therefore sought to investigate the role of cyclin E in MM. CCNE1 expression was found to be heterogeneous in various MM cell lines (hMMCLs). Incubation of hMMCLs with seliciclib, a selective CDK-inhibitor, results in apoptosis which is accompanied by down regulation of MCL1 and p27. Ectopic over expression of CCNE1 resulted in reduced sensitivity of the MM tumor cells in comparison to the paternal cell line, whereas CCNE1 silencing with siRNA increased the cell sensitivity to seliciclib. Adhesion to FN of hMMCLs was prevented by seliciclib, eliminating adhesion–mediated drug resistance of MM cells. Combination of seliciclib with flavopiridol effectively reduced CCNE1 and CCND1 protein levels, increased subG1 apoptotic fraction and promoted MM cell death in BMSCs co-culture conditions, therefore over-coming stroma-mediated protection. We suggest that seliciclib may be considered as essential component of modern anti MM drug combination therapy